Reactivating p53 to improve therapy in gynecologic cancers
收藏NIAID Data Ecosystem2026-05-10 收录
官方服务：
资源简介：
The development of resistance to PARP inhibitors is a major problem and a cause of treatment failures in advanced gynecologic cancers, and we show that adding a p53 reactivator such as HO-3867 enhances the efficacy of PARP inhibitors in p53-mutant cancer models.
创建时间：
2025-09-19
